Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE in a Case of Concurrent Neuroendocrine Tumors and Meningioma: Achieving Two Things in a Single Action

We present a partial response of peptide receptor radionuclide therapy (PRRT) with (177)Lu-DOTATATE in a case of concurrent neuroendocrine tumors (NETs) and meningioma. In addition to the valuable role of PRRT in inoperable NETs, it has been demonstrated that this treatment can be a promising therap...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Imaging Radionucl Ther
Autors principals: Assadi, Majid, Rekabpour, Seyed Javad, Amini, Abdullatif, Dadgar, Habibollah, Nemati, Reza, Gholamrezanezhad, Ali, Nabipour, Iraj, Jafari, Esmail, Ahmadzadehfar, Hojjat
Format: Artigo
Idioma:Inglês
Publicat: Galenos Publishing 2021
Matèries:
Interesting Image
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8185482/
https://ncbi.nlm.nih.gov/pubmed/34082512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/mirt.galenos.2020.69783
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars